We are Neutral on Indoco Remedies Ltd 3QFY2016 Results - Angel Broking Pvt Ltd

Below is the view on Indoco Remedies Ltd 3QFY2016 Results By Ms. Sarabjit Kour Nangra (VP Research - Pharma, Angel Broking Pvt Ltd)

“Indoco Remedies results were in line with expectations, on sales front, while net profit was lower on back of the lower than expected OPM’s. On sales the company posted sales of INR 255cr (V/s INR 257cr estimated), a YoY

We maintain our Buy rating on United Phosphorus Ltd 3QFY2016 Results - Angel Broking Pvt Ltd

Below is the view on United Phosphorus Ltd 3QFY2016 Results By Ms. Sarabjit Kour Nangra (VP Research - Pharma, Angel Broking Pvt Ltd)

“United Phosphorus Ltd posted sales of INR 3050cr, a YoY growth of 1.3% in 3QFY2016. The sales were impacted as all the key markets during the quarter were under pressure, while USA and Latin America posted a 12% and 14% YoY g

We recommend Accumulate rating on ICICI Bank Ltd 3QFY2016 Results - Angel Broking Pvt Ltd

Below is the view on ICICI Bank Ltd 3QFY2016 Results Mr. Vaibhav Agrawal (VP Research- Banking, Angel Broking Pvt Ltd)

“ICICI Bank reported disappointing set of number for 3QFY2016 results with PAT growth of 4.5% YoY to INR 3,018cr in 3QFY2016 which was below our expectations. NII grew at steady pace of 13.3% YoY which was in-line with the expectations likel

Reuters Poll: Jaitley can let deficit slip, go for growth - economists

By Krishna Eluri and Douglas Busvine

BENGALURU/NEW DELHI - Finance Minister Arun Jaitley would get away with letting his borrowing targets slip when he presents his annual budget next month, according to the overwhelming majority of economists in a Reuters poll.

Half the 30 economists surveyed also said the most pressing priority for Jaitley

We maintain our Neutral view on HDFC Ltd 3QFY2016 Results - Angel Broking Pvt Ltd

Below is the view on HDFC Ltd 3QFY2016 Results By Mr. Vaibhav Agrawal (VP Research- Banking, Angel Broking Pvt Ltd)

“HDFC Limited 3QFY2016 standalone net profit surged 6.7% YoY to INR 1,521cr. The lower growth in the profit for 3QFY2016 is due to lower  non-core income i.e. profit on sale of investments was INR 57cr  as against INR 113cr for 3

Hindustan Media Ventures Ltd 3QFY2016 Result - Angel Broking Pvt Ltd

Below is the view on Hindustan Media Ventures Limited 3QFY2016 Results Mr. Amarjeet Maurya (Sr. Research Analyst– MidCaps, Angel Broking Pvt Ltd)

“For 3QFY2016, Hindustan Media  Ventures Ltd (HMVL) reported earnings above our estimates. The top-line grew by ~16% YoY to ~INR 240cr, mainly due to decent growth in both the segments, i.e. (a) advertis

We maintain our BUY rating on HDFC Bank 3QFY2016 Result - Angel Broking Pvt Ltd

Below is the view on HDFC Bank 3QFY2016 Results By Mr. Vaibhav Agrawal (VP Research- Banking, Angel Broking Pvt Ltd)

“HDFC bank continued its trend of delivering consistent earnings performance quarter after quarter and registered a net interest income growth of 24.0% YoY for 3QFY2016 which was slightly above our expectations. The bank’s loan book grew

RBI seen easing only once this year as inflation climbs - Reuters poll

By Aaradhana Ramesh

BENGALURU  - The Reserve Bank of India (RBI) is expected to leave its key interest rate steady at 6.75 percent next week and only make one cut this year as rising inflation ties its hands, according to a Reuters poll.

That marks a turn from rapidly cooling domestic consumer price inflation, which allowed the RBI to l

We expect Nifty to extend its rebound in the coming week as well - Religare Securities Ltd

Below is the view on weekly Market outlook by Mr. Jayant Manglik, President, Retail Distribution, Religare Securities Ltd.

Amid excessive news flow, Nifty traded volatile in the passing week but somehow managed to close on flat note. Sentiments were downbeat from the beginning over the looming concerns of global weakness and relentless fall in crude. Though slight

We maintain our Neutral rating On Alembic Pharmaceuticals 3QFY2016 Result - Angel Broking Pvt Ltd

Below is the view on Alembic Pharmaceuticals- 3QFY2016 Results By Ms. Sarabjit Kour Nangra (VP Research - Pharma, Angel Broking Pvt Ltd)

“During 3QFY2016, the company posted results better than expected. On sales the company posted an 81.8% YoY growth in INR 921cr V/s INR 507cr in 3QFY2015 (INR 700cr expected). The Sales growth was mainly driven by the Inter

We maintain our BUY rating on HCL Technologies- 2QFY2016 Results - Angel Broking Pvt Ltd

Below is the view on HCL Technologies- 2QFY2016 Results By Ms. Sarabjit Kour Nangra (VP Research - IT, Angel Broking Pvt Ltd)

“During 2QFY2016, the company posted results better than expected. On sales the company posted a 1.4% QoQ growth in USD revenues to US$ 1,566mn V/s US$ 1,568mn expected. On Constant Currency, (CC) the company posted a 2.1% QoQ. In rup

We remain Neutral on Rallis India- 3QFY2016 Results - Angel Broking Pvt Ltd

Below is the view on Rallis India- 3QFY2016 Results By Ms. Sarabjit Kour Nangra (VP Research - Pharma, Angel Broking Pvt Ltd)

“For 3QFY2016, the company posted net sales and profit of INR 306cr and INR 20cr. This was against the sales and net profit of INR 386cr and INR 25cr during the last corresponding period. The OPMs came to around 6% V/s 9% during the l

Expert Views - China Q4 GDP eases to 6.8 pct y/y, meets expectations; December data disappoint

BEIJING  - China's economic growth eased to 6.8 percent in the fourth quarter from a year earlier, matching expectations but still the slowest since the global financial crisis, putting pressure on policymakers to roll out more support measures as fears of a sharper slowdown pummel global financial markets.

Analysts polled by Reuters had predicted g

Exports continue to slide albeit at slower pace, while non-oil imports zoom back - Religare Capital markets Ltd

Below is the view on India Economics By Mr. Jay Shankar, Chief India Economist & Director, Religare Capital markets Ltd

Foreign trade data were released for December 2015. The numbers are in line with our growth trajectory for FY16.
 
Exports declined by 14.8% in Dec’15. This was the 13th consecutive month of decline. For April-Dec&r

We maintain our BUY rating on Wipro 3QFY2016 Result - Angel Broking Pvt Ltd

Below is the view on Wipro- 3QFY2016 Results By Ms. Sarabjit Kour Nangra (VP Research - IT, Angel Broking)

Wipro (CMP: INR543/ TP: Under Review: Buy / Upside):

“During 3QFY2016, the company posted numbers lower than expected on all fronts. The IT services posted a 0.3% sequential growth in USD revenues to US$ 1,838mn V/s US$ 1,841